Low-grade SCI has also been extensively linked to disturbances in glucometabolic pathways as observed in people with type 2 diabetes (T2D), with the most consistent being for leukocytes and the strongest for CRP (Duncan et al., 2003; Noordam et al., 2018; Elimam et al., 2019; Scheithauer et al., 2020). The gene discussed is CRP; the disease is type 2 diabetes mellitus.